TP53 and head and neck squamous cell carcinoma: Of the 14,353 marginally significant co-mutations from TCGA, only one (TP53:DNAH5, HR = 2.00, 95% CI 1.26–3.17) was from the head and neck squamous cell carcinoma (HNSC) cohort, and all the rest came from UCEC.